Summary:
hc1 + Accumen have launched next-generation Clinical Excellence solutions, leveraging AI-driven lab data analysis to enhance patient care, reduce unnecessary procedures, and optimize blood transfusion management.
Takeaways:
- AI-Driven Insights – hc1’s machine learning technology translates lab data into actionable insights, improving patient outcomes and reducing costs.
- Optimized Blood Management – The solutions help reduce unnecessary transfusions by up to 30%, ensuring safer care and a stable blood supply.
- Strategic Healthcare Impact – hc1’s technology supports hospitals in enhancing patient care while driving system-wide efficiency and profitability.
hc1 + Accumen have introduced its next-generation Clinical Excellence solutions, a comprehensive suite of software and services that improve patient health through personalized diagnostic lab testing and optimized blood transfusion management. By translating lab data into actionable insights for clinicians, hc1 Clinical Excellence tells the story of an individual’s health across the patient care journey to predict patient needs, minimize avoidable illness, and eliminate unnecessary costs.
hc1’s clinician-built solutions use patented machine learning and AI-driven technology to analyze tens of millions of critical lab values and generate in-depth, personalized insights for every patient’s care journey. According to the Centers for Disease Control and Prevention, lab tests are crucial for monitoring patient health and inform 70% of healthcare decisions.
“When analyzed holistically, lab test results hold incredible promise to optimize an individual’s health journey from birth to death,” says hc1 CEO, Founder, and Chairman Bradley Bostic. “As the leader in transforming lab data into actionable insights, hc1 is the ideal partner for CEOs to tap into the strategic opportunity for the lab to improve patient health while increasing system-wide profits.”
Clinical Excellence Solutions Designed to Avoid Needless Procedures
hc1’s Clinical Excellence solutions were developed to improve a patient’s quality of life, avoid needless procedures, and support sustainable clinical advancements. They use real-time analytics to eliminate outdated tests, identify high-risk patients through lab results analysis, and reduce unnecessary transfusions by up to 30%, promoting safer care and a stable blood supply.
“hc1 + Accumen’s technology pays for itself. It helps us to see more patients with more information better,” Assistant Professor of Anesthesiology and Perioperative Medicine at Oregon Health & Science University (OHSU) School of Medicine Jeffrey Wagner, DNP. “Likewise, their people have been extremely helpful in working with us to establish this program at OHSU. They anticipate, respond, and become professional colleagues and partners. The idea is to be brave, implement, and reap the benefits for your patients and hospital system. To that end, hc1 + Accumen is essential for any hospital who wants to move that one step forward, and then two steps forward, to address all of its patient blood management interests.”
Featured Image: Angellodeco | Dreamstime.com
